• Epalrestat: Aldose Reductase Inhibitor for Oxidative Stress

  2026-06-12

  Epalrestat is a high-purity aldose reductase inhibitor with proven efficacy in oxidative stress and neuroprotection research. Recent evidence demonstrates its dual action in polyol pathway inhibition and KEAP1/Nrf2 pathway activation, supporting its use in diabetic neuropathy and Parkinson's disease models.

• P/Q-Type Calcium Channel Blockade Fails to Protect Against V

  2026-06-12

  This study rigorously tested whether blockade of P- and Q-type voltage-gated calcium channels with ω-agatoxin IVA mitigates excitotoxic neuronal injury in cortical cultures. The results demonstrate that, despite inhibiting glutamate release, P/Q-type channel antagonism does not reduce veratridine- or ouabain-induced toxicity, highlighting crucial mechanistic distinctions in excitotoxic pathways and refining experimental approaches for sodium channel dynamics and excitotoxicity research.

• Trypsin in Translational Research: Mechanisms & Strategies

  2026-06-11

  Explore how Trypsin, a hallmark serine protease, is reshaping translational research by driving mechanistic insights from cell proliferation and wound healing to advanced membrane fusion studies. This article bridges molecular understanding with strategic workflow recommendations, integrates findings from cutting-edge NIR-II photothermal therapy research, and positions APExBIO’s Trypsin (BA5744) as a cornerstone for innovation beyond standard product pages.

• Coumestrol Triggers Ferroptosis in RA Synoviocytes via PMAIP

  2026-06-11

  A recent study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) by stabilizing mitochondrial PMAIP1. This mechanism suppresses cell proliferation and inflammation, highlighting a novel therapeutic angle for RA intervention.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui

  2026-06-10

  DiI (DiIC18(3)) provides high-contrast, selective plasma membrane labeling for neuronal tracing, cell migration, and membrane analysis in both live and fixed samples. It is not suitable for water-based staining protocols or for targeting intracellular organelles. Strict protocol adherence and solvent selection are required to maintain membrane specificity.

• Veratridine (SKU B7219): Data-Backed Solutions for Sodium Ch

  2026-06-10

  This article delivers a scenario-driven, evidence-based exploration of Veratridine (SKU B7219) as a robust voltage-gated sodium channel opener for cell viability, excitotoxicity, and screening assays. Focused on real laboratory challenges, it demonstrates how Veratridine ensures reproducibility, sensitivity, and workflow clarity for biomedical researchers.

• Butylated Hydroxyanisole (BHA): Applied Antioxidant Workflow

  2026-06-09

  Butylated hydroxyanisole (BHA) is a benchmark synthetic antioxidant for advanced oxidative stress research, enabling highly reproducible ROS modulation and cellular protection studies. This article delivers hands-on workflow enhancements, troubleshooting advice, and actionable protocol parameters for maximizing BHA's value in real-world experiments.

• AZD2461 (SKU A4164): Reliable PARP Inhibition for Cancer Lab

  2026-06-09

  This article explores practical challenges in cell-based cytotoxicity assays and demonstrates how AZD2461 (SKU A4164) delivers reproducible, data-backed solutions for breast cancer research. Through scenario-driven Q&A, it addresses protocol optimization, result interpretation, and vendor selection with direct, literature-based evidence, highlighting the advantages of sourcing AZD2461 from APExBIO.

• P/Q-Type Calcium Channels and Excitotoxicity: Insights from

  2026-06-08

  This study rigorously tests whether P/Q-type calcium channel inhibition by ω-agatoxin IVA confers neuroprotection against excitotoxic injury in cortical neurons. The findings show that, despite reducing glutamate release, ω-agatoxin IVA does not prevent veratridine- or NMDA-induced toxicity, refining our mechanistic understanding of excitotoxicity and sodium channel opener models.

• Veratridine as a Voltage-Gated Sodium Channel Opener: Applie

  2026-06-08

  Veratridine unlocks advanced sodium channel research, enabling precise modeling of excitotoxicity and seizure mechanisms while offering unique oncology applications. This guide delivers actionable protocols, troubleshooting insights, and practical bridges from recent reference studies, positioning APExBIO’s Veratridine as an indispensable tool for translational science.

• Dexamethasone: Glucocorticoid Anti-Inflammatory Workflow Gui

  2026-06-07

  Dexamethasone (DHAP) is a synthetic glucocorticoid anti-inflammatory that enables reproducible modulation of immune responses, stem cell differentiation, and neuroinflammation in both cell and animal models. This article details optimized workflows, troubleshooting strategies, and cutting-edge use cases that leverage APExBIO’s Dexamethasone (DHAP) for advanced experimental success.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-06-06

  This study demonstrates that activating PPARγ regulates the balance between M1 and M2 macrophage polarization, effectively reducing inflammation in a mouse model of dextran sulfate sodium (DSS)-induced inflammatory bowel disease. By elucidating the STAT-1/STAT-6 pathway’s involvement, the research advances mechanistic understanding and highlights new directions for immunometabolic intervention.

• Sea Buckthorn Extract Suppresses Ferroptosis in COPD via ROS

  2026-06-05

  This study reveals that sea buckthorn extract (SBE) alleviates chronic obstructive pulmonary disease (COPD) by inhibiting ferroptosis in bronchial epithelial cells. SBE achieves this through direct scavenging of reactive oxygen species (ROS) and blockade of p53/MAPK pathways, highlighting a novel mechanism with potential translational relevance for oxidative stress-related lung diseases.

• Acetylation-Dependent Spliceosome Control in HCC and PARPi R

  2026-06-05

  This study reveals that acetylation of the spliceosome core component SmD2 regulates DNA damage repair and alternative splicing in hepatocellular carcinoma (HCC). Targeting SmD2 acetylation status—particularly via HDAC2 inhibition—can sensitize HCC cells to PARP inhibitors, suggesting new strategies for precision combination therapies.

• Decoding Necrosome Assembly: Optimal RIP3 Stoichiometry in N

  2026-06-04

  The referenced study provides a quantitative and mechanistic analysis of necrosome assembly, revealing that a specific RIP3:RIP1 stoichiometry is crucial for efficient necroptotic signaling. These insights refine our understanding of regulated cell death and offer practical guidance for experimental design in apoptosis and necroptosis research.

554 records 15/37 page Previous Next First page 上5页 1112131415 下5页 Last page